The management and long-term results of Japanese pediatric liver transplant recipients.
We investigated the long-term results and ongoing management issues of 39 Japanese children who underwent liver transplantation in Brisbane, Australia. Whole liver grafts were used in 15 patients (Wh group) and reduced-size grafts were used in 24 patients (Re group). The 1-year and 3-year survival rates were 74% and 60%, respectively, and all cases of late mortality which occurred after 6 months were due to infection. Statistical analysis showed no differences between the Wh and Re groups with regard to late mortality or liver function tests, although 4 of 24 (16.7%) patients from the Re group developed a recurrence of esophageal varices. Three patients treated with cyclosporine developed lymphoproliferative disorders following transplantation, but none of the patients developed severe nephrotoxicity or hypertension. Although a "catch-up" gain in weight was observed, poor growth in height was displayed, and there were no differences between the Wh and Re groups in this regard. Thus, we conclude that late complications of liver transplantation in children are common and further studies are necessary to evaluate the ongoing growth problems.
Ishikawa
M
M
Queensland Liver Transplant Service, Wolloongabba, Brisbane, Australia.
Kitatani
H
H
Akiyama
T
T
Shimizu
Y
Y
Balderson
G A
GA
Shepherd
R W
RW
Lynch
S V
SV
Ong
T H
TH
Strong
R W
RW
D001315:Australia; D001656:Biliary Atresia / Q000401:mortality / Q000601:surgery*; D001827:Body Height / Q000502:physiology; D001835:Body Weight / Q000502:physiology; D002102:Cadaver; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D007223:Infant; D007564:Japan / Q000208:ethnology; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D009929:Organ Size / Q000502:physiology; D011183:Postoperative Complications / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate
D007166:Immunosuppressive Agents